By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biovitrum AB 

Lindhagensgatan 133

Stockholm    SE-112 76  Sweden
Phone: 46-8-697-20-00 Fax:



Start Up

Company News
Swedish Orphan Biovitrum AB: Sobi Publishes Its Report For The Third Quarter 2016, Raises Guidance 10/27/2016 11:19:07 AM
Swedish Orphan Biovitrum AB's Hemophilia A Therapy Receives European Commission Orphan Drug Designation 9/23/2010 11:45:36 AM
New Number of Shares and Votes in Swedish Orphan Biovitrum AB 8/31/2010 11:42:26 AM
Swedish Orphan Biovitrum AB's Kineret(R) has Received Orphan Drug Designation in the USA 8/26/2010 8:59:43 AM
Presentation of Biovitrum AB's Interim Report January - June, 2010 7/13/2010 2:06:49 PM
Biogen Idec, Inc. (North Carolina) (BIIB) and Swedish Orphan Biovitrum AB Announce Decision to Advance Long- Lasting Hemophilia A Therapy into a Registrational Trial 7/9/2010 10:02:54 AM
Swedish Orphan Biovitrum AB and Dongbao announce Commercial Alliance for the Chinese and European markets 7/6/2010 11:07:15 AM
Change of Company Name for Biovitrum AB 6/21/2010 9:33:11 AM
Swedish Orphan Biovitrum AB And Biomodels To Develop Assay For Mucositis Risk In Cancer Treatment 5/11/2010 1:42:51 PM
Swedish Orphan Biovitrum AB Presents First Positive Kiobrina(R) Clinical Phase II Data 5/6/2010 11:11:50 AM